Hims & Hers Health (HIMS) grants CTO Mohamed Elshenawy 1.2M RSUs

Rhea-AI Filing Summary

Elshenawy Mohamed reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. reported that CTO Mohamed Elshenawy received a grant of 1,200,000 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Class A Common Stock. The RSUs carry a service-based vesting requirement over 3 years, vesting in substantially equal quarterly installments starting on the first company quarterly vesting date following the grant. Following this award, Elshenawy holds 1,200,000 RSUs directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Elshenawy Mohamed

Role CTO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit F1, F2	1,200,000	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 1,200,000 shares (Direct)

Footnotes (2)

1. F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. F2. The RSUs shall be subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with the RSUs vesting in substantially equal quarterly installments on the applicable Company quarterly vesting dates, with the first of such vesting dates to be the first Company quarterly vesting date to occur following the grant date of the award.

Key Figures

RSUs granted: 1,200,000 RSUs Total RSUs after grant: 1,200,000 RSUs Vesting period: 3 years +2 more

5 metrics

RSUs granted 1,200,000 RSUs Grant of Restricted Stock Units to CTO on 2026-08-12

Total RSUs after grant 1,200,000 RSUs Total RSUs held directly by CTO following the transaction

Vesting period 3 years Service-based vesting requirement for RSU award

Vesting frequency Quarterly installments RSUs vest in substantially equal quarterly installments

Transaction price per RSU $0.00 Grant, award, or other acquisition with no purchase price

Key Terms

Restricted Stock Unit, service-based vesting requirement, quarterly vesting dates

3 terms

Restricted Stock Unit financial

"The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

service-based vesting requirement financial

"The RSUs shall be subject to a service-based vesting requirement, which shall be satisfied"

quarterly vesting dates financial

"vesting in substantially equal quarterly installments on the applicable Company quarterly vesting dates"

FAQ

What insider transaction did HIMS report for CTO Mohamed Elshenawy?

Hims & Hers Health (HIMS) reported a grant of 1,200,000 Restricted Stock Units to CTO Mohamed Elshenawy, each RSU representing a contingent right to receive one share of Class A Common Stock, subject to time-based vesting.

How many RSUs did the HIMS CTO hold after this Form 4 transaction?

After the reported transaction, the Hims & Hers Health (HIMS) CTO held 1,200,000 RSUs. These RSUs were newly granted in this award and are subject to a three-year service-based vesting schedule in quarterly installments.

What is the vesting schedule for the 1,200,000 RSUs granted by HIMS?

The 1,200,000 RSUs granted by Hims & Hers Health (HIMS) to its CTO vest over three years in substantially equal quarterly installments, beginning on the first company quarterly vesting date that occurs after the grant date of the award.

What does each RSU granted by Hims & Hers Health (HIMS) represent?

Each RSU granted by Hims & Hers Health (HIMS) to the CTO represents a contingent right to receive one share of the company’s Class A Common Stock, subject to the RSU’s service-based vesting requirements being satisfied.

Was the RSU grant to the HIMS CTO a market purchase or a compensation award?

The RSU grant to the Hims & Hers Health (HIMS) CTO was reported as a grant, award, or other acquisition at a price of $0.00 per unit, indicating it is a compensation-related equity award rather than a market purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/14/2026 - 04:23 PM Accepted by SEC EDGAR 08/14/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elshenawy Mohamed

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CTO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	08/12/2026		A		1,200,000		(2)	(2)	Class A Common Stock	1,200,000	$0	1,200,000	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs shall be subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with the RSUs vesting in substantially equal quarterly installments on the applicable Company quarterly vesting dates, with the first of such vesting dates to be the first Company quarterly vesting date to occur following the grant date of the award.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Mohamed Elshenawy	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)